Augmedix Announces Participation in Oppenheimer’s 33rd Annual Healthcare Conference
SAN FRANCISCO, March 07, 2023 (GLOBE NEWSWIRE) — Augmedix Inc. (Nasdaq:AUGX), a healthcare technology company that delivers industry-leading, ambient medical documentation and data solutions, today announced that Manny Krakaris, Chief Executive Officer, and Paul Ginocchio, Chief Financial Officer will attend and present at the Oppenheimer 33rd Annual Healthcare Conference taking place virtually on March 13 – 15, 2023.
Related news for (AUGX)
- Commure to Acquire Augmedix
- Augmedix Announces Participation in Maxim Group Virtual Healthcare IT Investor Conference
- Augmedix Exits Calendar 2023 with Expected $51 Million in Annual Recurring Revenue
- Augmedix Partners with Google Cloud to Bring Medically-Tuned AI Technology to Ambient Documentation
- Augmedix Partners with Google Cloud to Bring Medically-Tuned AI Technology to Ambient Documentation